Abstract

ObjectiveAutomatic syringe dispensing machines (ADM) have become an important adjunct to Australia's needle and syringe programs (NSP). However, concerns that they reduce face‐to‐face contact with health staff and other health interventions remain. We examined changes in the number of needle/syringes dispensed at an ADM and occasions of service at a co‐located face‐to‐face NSP and targeted primary healthcare clinic during the first wave of COVID‐19 restrictions. MethodsWe reviewed data from an inner‐city harm reduction program during the study period of April 2020 to March 2021 compared to the previous year. Multivariable linear regression models were used to estimate the association between occasions of service and equipment distribution. ResultsADM‐dispensed equipment increased significantly by 41.1%, while face‐to‐face NSP occasions decreased by 16.2%. Occasions provided by the targeted primary healthcare clinic increased by 59.7% per month. ConclusionWe have shown that 24‐hour ADM access did not adversely affect the number of people using targeted primary healthcare when provided within close proximity. Implication for public healthThese findings reinforce the demand for 24‐hour needle/syringe access and can be used to support the expanded access to ADMs, especially where people who inject drugs (PWID) have access to appropriate healthcare.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.